Cargando…

KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is considered to be one of the most aggressive cancers. Our previous study proved that highly expressed lysine acetyltransferase 5 (KAT5) in ATC is associated with a poorer prognosis. Here, this study examined the effects of a KAT5 inhibitor (NU9056) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wenjing, Xie, Liwei, Yang, Yingying, Xu, Jiayu, Cai, Shang, Tian, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279498/ https://www.ncbi.nlm.nih.gov/pubmed/37342240 http://dx.doi.org/10.1155/2022/2014568

Ejemplares similares

Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
por: Coffey, Kelly, et al.
Publicado: (2012)

NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice
por: Chen, Lu, et al.
Publicado: (2021)

Knockdown of KAT5/KIF11 induces autophagy and promotes apoptosis in anaplastic thyroid cancer cells
por: Fu, Lei, et al.
Publicado: (2023)

miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma
por: Deng, Xinchao, et al.
Publicado: (2017)

Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
por: Christoffersen, Berit Ø., et al.
Publicado: (2019)

Search for resonant $\nu$ production at $\sqrt{s}$ =202 to 208 GeV
por: Ledroit-Guillon, F
Publicado: (2001)

MiR-599 serves a suppressive role in anaplastic thyroid cancer by activating the T-cell intracellular antigen
por: Bi, Jian Wei, et al.
Publicado: (2019)

miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression
por: Zhuang, Donghai, et al.
Publicado: (2020)

Anaplastic multiple myeloma with MYC rearrangement
por: Ichikawa, Satoshi, et al.
Publicado: (2021)

Search for resonant $\widetilde{\nu}$ production at $\sqrt{s}$=202 to 208 GeV
por: Ledroit-Guillon, F
Publicado: (2002)

Search for resonant \tilde\nu production at Vs=202 to 208 GeV
por: Ledroit-Guillon, F
Publicado: (2000)

MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
por: Xiong, Yin, et al.
Publicado: (2014)

miR-19a Is Involved In Progression And Malignancy Of Anaplastic Thyroid Cancer Cells
por: Calabrese, Giovanna, et al.
Publicado: (2019)

MiR-202-3p determines embryo viability during mid-blastula transition
por: Hu, Ruiqin, et al.
Publicado: (2022)

MiR-202 controls female fecundity by regulating medaka oogenesis
por: Gay, Stéphanie, et al.
Publicado: (2018)

miR-143-3p represses leukemia cell proliferation by inhibiting KAT6A expression
por: Xu, Dan, et al.
Publicado: (2021)

Constraints on Anomalous Quartic Gauge Boson Couplings from $e^+ e^- \to \nu\overline{\nu}gg(g)$ at 189-202 GeV
por: Jacholkowska, A, et al.
Publicado: (2001)

MiRNA-202-5p promotes Colorectal Carcinogenesis through suppression of PTEN
por: Huang, Jing, et al.
Publicado: (2021)

Biomarker Value of miR-221 and miR-222 as Potential Substrates in the Differential Diagnosis of Papillary Thyroid Cancer Based on Data Synthesis and Bioinformatics Approach
por: Cai, Shang, et al.
Publicado: (2022)

miRNA Expression in Anaplastic Thyroid Carcinomas
por: Hébrant, Aline, et al.
Publicado: (2014)

miR-202 functions as a tumor suppressor in hepatocellular carcinoma by targeting HK2
por: Wang, Jiangang, et al.
Publicado: (2020)

The Role of Tracheostomy in Anaplastic Thyroid Carcinoma
por: Xu, Jia, et al.
Publicado: (2015)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1
por: Zhang, Wei, et al.
Publicado: (2019)

Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer
por: Kishikawa, Masahiro, et al.
Publicado: (2021)

miR-193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma
por: Gao, Jinjian, et al.
Publicado: (2020)

Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells
por: Li, Yi-Tian, et al.
Publicado: (2018)

Localization and in silico‐based functional analysis of miR‐202 in bull testis
por: Mohammed, Bushra T., et al.
Publicado: (2022)

Knockdown of lncRNA NEAT1 suppresses hypoxia-induced migration, invasion and glycolysis in anaplastic thyroid carcinoma cells through regulation of miR-206 and miR-599
por: Tan, Xiangrong, et al.
Publicado: (2020)

Silencing of KCNK15-AS1 inhibits lung cancer cell proliferation via upregulation of miR-202 and miR-370
por: Peng, Jun, et al.
Publicado: (2019)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)

Exosomal miR-202 derived from leukorrhea as a potential biomarker for endometriosis
por: Zheng, Li, et al.
Publicado: (2023)

c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism
por: Gao, Ping, et al.
Publicado: (2009)

MYC and MiR: vicious circle
por: Zhao, Xiaohong, et al.
Publicado: (2013)

miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells
por: Wang, Hantao, et al.
Publicado: (2015)

Age Influences the Prognosis of Anaplastic Thyroid Cancer Patients
por: Kong, Na, et al.
Publicado: (2021)

KATs in Cancer: Functions and Therapies
por: Farria, Aimee, et al.
Publicado: (2015)

miR-450-5p and miR-202-5p Synergistically Regulate Follicle Development in Black Goat
por: Feng, Guanghang, et al.
Publicado: (2022)

lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
por: Zhang, Jianhua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fqceqkrg9rrser7f3qh7enti0c